Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8101)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2013 (publication date) through Jun 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ren F, Sheng WQ, Du X. CD133: A cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol 2013; 19(17): 2603-2611 [PMID: 23674867 DOI: 10.3748/wjg.v19.i17.2603] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i17/2603.htm |
| Number | Citing Articles |
| 1 |
Cynthia M Simbulan-Rosenthal, Nusrat Islam, Yogameenakshi Haribabu, Ryyan Alobaidi, Azadeh Shalamzari, Garrett Graham, Li-Wei Kuo, Peter Sykora, Dean S Rosenthal. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma. Cells 2024; 13(9): 777 doi: 10.3390/cells13090777
|
| 2 |
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, Reni Kitte, Sarah Dluczek, Alexander Strauß, André-René Blaudszun, Tetyana Yevsa, Stephan Fricke, Uta Kossatz-Boehlert. Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01280
|
| 3 |
Jeremy Martin, Farhadul Islam. Cancer Stem Cells: Basic Concept and Therapeutic Implications. 2023; : 45 doi: 10.1007/978-981-99-3185-9_3
|
| 4 |
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
|
| 5 |
Loredana G. Marcu, Leyla Moghaddasi, Eva Bezak. Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells. International Journal of Molecular Sciences 2023; 24(2): 1524 doi: 10.3390/ijms24021524
|
| 6 |
Junyi An, Xiaohua Hu, Feng Liu. Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1114621
|
| 7 |
Elaina Kwiatkowski, Shubhankar Suman, Bhaskar V. S. Kallakury, Kamal Datta, Albert J. Fornace, Santosh Kumar. Expression of Stem Cell Markers in High-LET Space Radiation-Induced Intestinal Tumors in Apc1638N/+ Mouse Intestine. Cancers 2023; 15(17): 4240 doi: 10.3390/cancers15174240
|
| 8 |
Irina Florina Cherciu Harbiyeli, Daniela Elena Burtea, Elena Tatiana Ivan, Ioana Streață, Elena Raluca Nicoli, Daniel Uscatu, Mircea-Sebastian Șerbănescu, Mihai Ioana, Peter Vilmann, Adrian Săftoiu. Assessing Putative Markers of Colorectal Cancer Stem Cells: From Colonoscopy to Gene Expression Profiling. Diagnostics 2022; 12(10): 2280 doi: 10.3390/diagnostics12102280
|
| 9 |
Tianyu Zhang, Jielin Xu, Siyuan Deng, Fengqi Zhou, Jin Li, Liwei Zhang, Lang Li, Qi-En Wang, Fuhai Li, Gianpaolo Papaccio. Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data. PLOS ONE 2018; 13(5): e0196351 doi: 10.1371/journal.pone.0196351
|
| 10 |
Masato Narita, Elie Oussoultzoglou, Marie‐Pierre Chenard, Pascal Fuchshuber, Tetsuro Yamamoto, Pietro Addeo, Daniel Jaeck, Philippe Bachellier. Predicting Early Intrahepatic Recurrence After Curative Resection of Colorectal Liver Metastases with Molecular Markers. World Journal of Surgery 2015; 39(5): 1167 doi: 10.1007/s00268-014-2916-1
|
| 11 |
Vahid Haghpanah, Parviz Fallah, Mahmood Naderi, Rezvan Tavakoli, Masoud Soleimani, Bagher Larijani. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma. Life Sciences 2016; 146: 34 doi: 10.1016/j.lfs.2015.12.057
|
| 12 |
Jessica Kopenhaver, Madison Crutcher, Scott A. Waldman, Adam E. Snook. The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission. Expert Opinion on Biological Therapy 2021; 21(10): 1335 doi: 10.1080/14712598.2021.1929167
|
| 13 |
Elisa Lambert, Rémi Manczak, Elodie Barthout, Sofiane Saada, Elena Porcù, Francesca Maule, Barbara Bessette, Giampietro Viola, Luca Persano, Claire Dalmay, Fabrice Lalloué, Arnaud Pothier. Microfluidic Lab-on-a-Chip Based on UHF-Dielectrophoresis for Stemness Phenotype Characterization and Discrimination among Glioblastoma Cells. Biosensors 2021; 11(10): 388 doi: 10.3390/bios11100388
|
| 14 |
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
|
| 15 |
Byung Soo Park, Seok Yun Jung, Sang Mo Kwon, Jae Ho Bae, Sun Min Lee, Dong Hoon Shin, Gyung Mo Son. Comparison of putative circulating cancer stem cell detection between the hepatic portal system and peripheral blood in colorectal cancer patients. Annals of Surgical Treatment and Research 2014; 87(5): 232 doi: 10.4174/astr.2014.87.5.232
|
| 16 |
Ke Xu, Ke Shen, Xin Liang, Yueqi Li, Norio Nagao, Jiyu Li, Jianwen Liu, Peihao Yin. MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells. Oncotarget 2016; 7(46): 75118 doi: 10.18632/oncotarget.12611
|
| 17 |
Tatsuzo Mizukami, Hirofumi Kamachi, Tomoko Mitsuhashi, Yosuke Tsuruga, Yutaka Hatanaka, Toshiya Kamiyama, Yoshihiro Matsuno, Akinobu Taketomi. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-687
|
| 18 |
Do Thi Thao, Le Nhat Minh, Tran Thi Minh Anh, Nguyen Thi Nga, Phung Thi Kim Hue, Phan Van Kiem. The Improved Anticancer Activities of Piperine Nanoliposome Conjugated CD133 Monoclonal Antibody Against NTERA-2 Cancer Stem Cells. Natural Product Communications 2021; 16(2): 1934578X2199818 doi: 10.1177/1934578X21998184
|
| 19 |
Sheng Wang, Dexi Zhou, Zhenyu Xu, Jing Song, Xueyi Qian, Xiongwen Lv, Jiajie Luan. Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect. Current Drug Targets 2019; 20(11): 1180 doi: 10.2174/1389450120666190402145325
|
| 20 |
Buxian Tian, Yuhong Zhang, Jing Zhang. Periostin is a new potential prognostic biomarker for glioma. Tumor Biology 2014; 35(6): 5877 doi: 10.1007/s13277-014-1778-3
|
| 21 |
Amir Barzegar Behrooz, Amir Syahir, Syahida Ahmad. CD133: beyond a cancer stem cell biomarker. Journal of Drug Targeting 2019; 27(3): 257 doi: 10.1080/1061186X.2018.1479756
|
| 22 |
Manali Haniti Mohd-Zahid, Rohimah Mohamud, Che Azurahanim Che Abdullah, JitKang Lim, Halima Alem, Wan Nurhidayah Wan Hanaffi, Iskandar Z. A.. Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles. RSC Advances 2020; 10(2): 973 doi: 10.1039/C9RA08192E
|
| 23 |
Xiaofeng Wang, Lu Chen, Zhongdi Xiao, Yali Wang, Tiemei Liu, Tianfu Zhang, Yucheng Zhang. Screening glioma stem cells in U251 cells based on the P1 promoter of the CD133 gene. Oncology Letters 2016; 12(4): 2457 doi: 10.3892/ol.2016.4966
|
| 24 |
Shweta Bisht, Manisha Nigam, Shyam S. Kunjwal, Plygun Sergey, Abhay Prakash Mishra, Javad Sharifi-Rad, Valeria Sorrenti. Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. Stem Cells International 2022; 2022: 1 doi: 10.1155/2022/9653244
|
| 25 |
Gaetano Romano. The Role of the Dysfunctional Akt-Related Pathway in Cancer: Establishment and Maintenance of a Malignant Cell Phenotype, Resistance to Therapy, and Future Strategies for Drug Development. Scientifica 2013; 2013: 1 doi: 10.1155/2013/317186
|
| 26 |
Azadeh Fakhrioliaei, Sepideh Tanhaei, SeyedAbbas Pakmehr, Maha Noori Shakir, Maytham T. Qasim, Maryam Hariri, Alireza Nouhi Kararoudi, Mohammad Valilo. Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review. The Journal of Membrane Biology 2024; 257(1-2): 3 doi: 10.1007/s00232-024-00307-2
|
| 27 |
Roghayeh Mahmoudi, Saeid Afshar, Razieh Amini, Akram Jalali, Massoud Saidijam, Rezvan Najafi. Evaluation of BMP-2 as a Differentiating and Radiosensitizing Agent for
Colorectal Cancer Stem Cells. Current Stem Cell Research & Therapy 2024; 19(1): 83 doi: 10.2174/1574888X18666230330085615
|
| 28 |
Esra Aydemir Çoban, Fikrettin Şahin. Cell Biology and Translational Medicine, Volume 2. Advances in Experimental Medicine and Biology 2018; 1089: 97 doi: 10.1007/5584_2018_279
|
| 29 |
Yukie Yoshii, Takako Furukawa, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Yasushi Kiyono, Ming-Rong Zhang, Yasuhisa Fujibayashi, Tsuneo Saga. 64Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133+ cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite. Cancer Letters 2016; 376(1): 74 doi: 10.1016/j.canlet.2016.03.020
|
| 30 |
Nassiba Taib, Maysaloun Merhi, Varghese Inchakalody, Sarra Mestiri, Shereena Hydrose, Karama Makni-Maalej, Afsheen Raza, Fairooz Sahir, Fouad Azizi, Parveen B. Nizamuddin, Queenie Fernandes, Zeenath Safira K. M. Yoosuf, Salam Almoghrabi, Lobna Al-Zaidan, Alaaeldin Shablak, Shahab Uddin, Cristina Maccalli, Mohammed Ussama Al Homsi, Said Dermime. Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04073-y
|
| 31 |
Michael R. Hamblin, James D. Carroll, Praveen Arany, Heidi Abrahamse, Anine Crous. Biochemical responses of isolated lung CSCs after application of low intensity laser irradiation. Mechanisms of Photobiomodulation Therapy XI 2016; 9695: 96950J doi: 10.1117/12.2228902
|
| 32 |
Sweta Suman, Subhransu Kumar Hota, Pranati Misra, Nageswar Sahu, Subrat Sahu. Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma. Cureus 2023; doi: 10.7759/cureus.41242
|
| 33 |
Takeharu Shiroki, Misa Yokoyama, Nobuhiro Tanuma, Ryuhei Maejima, Keiichi Tamai, Kazunori Yamaguchi, Tomoyuki Oikawa, Tetsuya Noguchi, Koh Miura, Tsuneaki Fujiya, Hiroshi Shima, Ikuro Sato, Naoko Murata‐Kamiya, Masanori Hatakeyama, Katsunori Iijima, Tooru Shimosegawa, Kennichi Satoh. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer‐specific metabolism. Cancer Science 2017; 108(5): 931 doi: 10.1111/cas.13211
|
| 34 |
Amaresh Mishra, Yamini Pathak, Surabhi Kirti Mishra, Hridayesh Prakash, Vishwas Tripathi. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis. European Journal of Pharmacology 2023; 938: 175412 doi: 10.1016/j.ejphar.2022.175412
|
| 35 |
Wei-Chih Kuan, Daniel Horák, Zdeněk Plichta, Wen-Chien Lee. Immunocapture of CD133-positive cells from human cancer cell lines by using monodisperse magnetic poly(glycidyl methacrylate) microspheres containing amino groups. Materials Science and Engineering: C 2014; 34: 193 doi: 10.1016/j.msec.2013.09.009
|
| 36 |
Jagat R Kanwar, Ganesh Mahidhara, Kislay Roy, Sreenivasan Sasidharan, Subramanian Krishnakumar, Neerati Prasad, Rakesh Sehgal, Rupinder K Kanwar. Fe-Blf Nanoformulation Targets Survivin to Kill Colon Cancer Stem Cells and Maintains Absorption of Iron, Calcium and Zinc. Nanomedicine 2015; 10(1): 35 doi: 10.2217/nnm.14.132
|
| 37 |
Zhenzhen Chen, Jiayi Wu, Benyu Liu, Guangtan Zhang, Zhiwei Wang, Lulu Zhang, Kaili Wang, Zusen Fan, Pingping Zhu. Identification of cis-HOX-HOXC10 axis as a therapeutic target for colorectal tumor-initiating cells without APC mutations. Cell Reports 2021; 36(4): 109431 doi: 10.1016/j.celrep.2021.109431
|
| 38 |
Ioannis A Voutsadakis. Pluripotency Transcription Factors in the Pathogenesis of Colorectal Cancer and Implications for Prognosis. Biomarkers in Medicine 2015; 9(4): 349 doi: 10.2217/bmm.15.4
|
| 39 |
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane, Chiara Modica, Vincenzo Davide Pantina, Narges Roozafzay, Simone Di Franco, Miriam Gaggianesi, Veronica Veschi, Melania Lo Iacono, Matilde Todaro, Alice Turdo, Giorgio Stassi. Cancer cell targeting by CAR-T cells: A matter of stemness. Frontiers in Molecular Medicine 2022; 2 doi: 10.3389/fmmed.2022.1055028
|
| 40 |
S. Attia, N. Atwan, M. Arafa, R. A. Shahin. Expression of CD133 as a cancer stem cell marker in invasive gastric carcinoma. Pathologica 2019; 111(1): 18 doi: 10.32074/1591-951X-51-18
|
| 41 |
Anna Lyberopoulou, Gerasimos Aravantinos, Efstathios P. Efstathopoulos, Nikolaos Nikiteas, Penelope Bouziotis, Athina Isaakidou, Apostolos Papalois, Evangelos Marinos, Maria Gazouli, Javier S Castresana. Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue. PLOS ONE 2015; 10(4): e0123902 doi: 10.1371/journal.pone.0123902
|
| 42 |
Laura L. Stafman, Adele P. Williams, Evan F. Garner, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Kimberly Whelan, Elizabeth A. Beierle. Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma. Translational Oncology 2019; 12(2): 200 doi: 10.1016/j.tranon.2018.10.008
|
| 43 |
Wanlu Li, Mi-Ra Lee, EunHee Choi, Mee-Yon Cho. Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer. Journal of Pathology and Translational Medicine 2017; 51(1): 17 doi: 10.4132/jptm.2016.09.23
|
| 44 |
Yu-Chen Tang, Yan Zhang, Jin Zhou, Qiaoming Zhi, Meng-Yao Wu, Fei-Ran Gong, Meng Shen, Lu Liu, Min Tao, Bairong Shen, Dong-Mei Gu, Jie Yu, Meng-Dan Xu, Yuan Gao, Wei Li. Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4183
|
| 45 |
Gabriela M. Chiocchetti, Dinoraz Vélez, Vicenta Devesa. Effect of chronic exposure to inorganic arsenic on intestinal cells. Journal of Applied Toxicology 2019; 39(6): 899 doi: 10.1002/jat.3778
|
| 46 |
Xiaoli Sheng, Yunxian Li, Yixuan Li, Wenlin Liu, Zhongming Lu, Jiandong Zhan, Mimi Xu, Liangsi Chen, Xiaoning Luo, Gang Cai, Siyi Zhang. PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6029-y
|
| 47 |
Chuan-Kai Chou, Chi-Chen Fan, Pei-Shan Lin, Pei-Yu Liao, Jia-Chen Tung, Chang-Hsun Hsieh, Mien-Chie Hung, Chung-Hsuan Chen, Wei-Chao Chang. Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis. Oncotarget 2016; 7(18): 25742 doi: 10.18632/oncotarget.8264
|
| 48 |
Morteza Akbari, Navid Shomali, Afsaneh Faraji, Dariush Shanehbandi, Milad Asadi, Ahad Mokhtarzadeh, Aliakbar Shabani, Behzad Baradaran. CD133: An emerging prognostic factor and therapeutic target in colorectal cancer. Cell Biology International 2020; 44(2): 368 doi: 10.1002/cbin.11243
|
| 49 |
Liqun Yang, Pengfei Shi, Gaichao Zhao, Jie Xu, Wen Peng, Jiayi Zhang, Guanghui Zhang, Xiaowen Wang, Zhen Dong, Fei Chen, Hongjuan Cui. Targeting cancer stem cell pathways for cancer therapy. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0110-5
|
| 50 |
Hui Li, JuHui Chen, Jie Liu, Yiqin Lai, Sha Huang, Liang Zheng, Nanfeng Fan. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism. Experimental Cell Research 2021; 409(1): 112892 doi: 10.1016/j.yexcr.2021.112892
|
| 51 |
Yuheng Du, Daojiang Li, Nanpeng Li, Chen Su, Chunxing Yang, Changwei Lin, Miao Chen, Runliu Wu, Xiaorong Li, Gui Hu. POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling. Cell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-1055-2
|
| 52 |
Kislay Roy, Rupinder K. Kanwar, Jagat R. Kanwar. LNA aptamer based multi-modal, Fe 3 O 4 -saturated lactoferrin (Fe 3 O 4 -bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging. Biomaterials 2015; 71: 84 doi: 10.1016/j.biomaterials.2015.07.055
|
| 53 |
Pratima Nangia-Makker, Yingjie Yu, Lulu Farhana, Kulsoom Ahmed, Adhip P. N. Majumdar. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. 2015; : 227 doi: 10.1007/978-3-319-21030-8_9
|
| 54 |
Ashleigh Pulkoski-Gross, Xi E. Zheng, Deborah Kim, Jillian Cathcart, Jian Cao. Intestinal Tumorigenesis. 2015; : 309 doi: 10.1007/978-3-319-19986-3_11
|
| 55 |
Ruizhi Geng, Niklas Harland, Ivonne A. Montes-Mojarro, Falko Fend, Wilhelm K. Aicher, Arnulf Stenzl, Bastian Amend. CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?. International Journal of Molecular Sciences 2022; 23(10): 5453 doi: 10.3390/ijms23105453
|
| 56 |
Kristina Vukovic Đerfi, Tea Vasiljevic, Tanja Matijevic Glavan. Recent Advances in the Targeting of Head and Neck Cancer Stem Cells. Applied Sciences 2023; 13(24): 13293 doi: 10.3390/app132413293
|
| 57 |
Zhenzhen Chen, Luyun He, Liangbo Zhao, Guangtan Zhang, Zhiwei Wang, Pingping Zhu, Benyu Liu. circREEP3 Drives Colorectal Cancer Progression via Activation of FKBP10 Transcription and Restriction of Antitumor Immunity. Advanced Science 2022; 9(13) doi: 10.1002/advs.202105160
|
| 58 |
Minjie Huang, Huijun Zhu, Jian Feng, Songshi Ni, Jianfei Huang. High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/986095
|
| 59 |
Shigeo Saito, Chia-Chen Ku, Kenly Wuputra, Jia-Bin Pan, Chang-Shen Lin, Ying-Chu Lin, Deng-Chyang Wu, Kazunari K. Yokoyama. Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application. Journal of Personalized Medicine 2022; 12(5): 715 doi: 10.3390/jpm12050715
|
| 60 |
Audrey Vincent, Aïcha Ouelkdite-Oumouchal, Mouloud Souidi, Julie Leclerc, Bernadette Neve, Isabelle Van Seuningen. Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies. World Journal of Stem Cells 2019; 11(11): 920-936 doi: 10.4252/wjsc.v11.i11.920
|
| 61 |
Anshuly Tiwari, Siddharth J. Modi, Satish Y. Gabhe, Vithal M. Kulkarni. Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT). Bioorganic Chemistry 2021; 110: 104776 doi: 10.1016/j.bioorg.2021.104776
|
| 62 |
Min-Cong Wang, Min Jiao, Tao Wu, Li Jing, Jie Cui, Hui Guo, Tao Tian, Zhi-ping Ruan, Yong-Chang Wei, Li-Li Jiang, Hai-Feng Sun, Lan-Xuan Huang, Ke-Jun Nan, Chun-Li Li. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study. Oncotarget 2016; 7(8): 9586 doi: 10.18632/oncotarget.7078
|
| 63 |
Federica Papaccio, Francesca Paino, Tarik Regad, Gianpaolo Papaccio, Vincenzo Desiderio, Virginia Tirino. Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development. Stem Cells Translational Medicine 2017; 6(12): 2115 doi: 10.1002/sctm.17-0138
|
| 64 |
Lorena Vázquez-Iglesias, Leticia Barcia-Castro, Marta Rodríguez-Quiroga, María Páez de la Cadena, Javier Rodríguez-Berrocal, Oscar J. Cordero. Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+cancer stem cells subsets. Biology Open 2019; doi: 10.1242/bio.041673
|
| 65 |
Hyeok-Won An, Sang Hyeok Seok, Jong-Wan Kwon, Anahita Dev Choudhury, Jeong-Seop Oh, Dominic C. Voon, Dae-Yong Kim, Jun Won Park. The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer. Cell Reports 2022; 41(13): 111878 doi: 10.1016/j.celrep.2022.111878
|
| 66 |
C. Z. You, H. Xu, F. S. Zhao, J. Dou. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells. Bulletin of Experimental Biology and Medicine 2024; 176(3): 369 doi: 10.1007/s10517-024-06026-x
|
| 67 |
Siddharth J. Modi, Vithal M. Kulkarni. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma. European Journal of Medicinal Chemistry 2020; 207: 112851 doi: 10.1016/j.ejmech.2020.112851
|
| 68 |
Joshua D. Greenlee, Kevin Liu, Maria Lopez-Cavestany, Michael R. King. Piezo1 Mechano-Activation Is Augmented by Resveratrol and Differs between Colorectal Cancer Cells of Primary and Metastatic Origin. Molecules 2022; 27(17): 5430 doi: 10.3390/molecules27175430
|
| 69 |
Tapas Pradhan, Krishnanand Padmanabhan, Manu Prasad, K. Chandramohan, S. Asha Nair. Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer. Journal of Cellular and Molecular Medicine 2019; 23(6): 3984 doi: 10.1111/jcmm.14284
|
| 70 |
Karama Makni Maalej, Maysaloun Merhi, Varghese P. Inchakalody, Sarra Mestiri, Majid Alam, Cristina Maccalli, Honar Cherif, Shahab Uddin, Martin Steinhoff, Francesco M. Marincola, Said Dermime. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01723-z
|
| 71 |
Katsuji Sawai, Takanori Goi, Youhei Kimura, Kenji Koneri. Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer. Cancers 2024; 16(8): 1556 doi: 10.3390/cancers16081556
|
| 72 |
A metabolic signature of colon cancer initiating cells. 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2014; : 4759 doi: 10.1109/EMBC.2014.6944688
|
| 73 |
JIANJUN ZHU, SHISHAN DENG, JIE DUAN, XINGGUO XIE, SHIQUAN XU, MAOCHENG RAN, XIAOSI DAI, YU PU, XIAOMING ZHANG. FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma. Oncology Letters 2014; 7(6): 2185 doi: 10.3892/ol.2014.2031
|
| 74 |
Luciano de S. Santos, Valdenizia R. Silva, Maria V. L. de Castro, Rosane B. Dias, Ludmila de F. Valverde, Clarissa A. G. Rocha, Milena B. P. Soares, Claudio A. Quadros, Edjane R. dos Santos, Regina M. M. Oliveira, Rose M. Carlos, Paulo C. L. Nogueira, Daniel P. Bezerra. New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone. Cell Death & Disease 2023; 14(12) doi: 10.1038/s41419-023-06330-w
|
| 75 |
Mariel E Toledo-Guzmán, Gabriele D Bigoni-Ordóñez, Miguel Ibáñez Hernández, Elizabeth Ortiz-Sánchez. Cancer stem cell impact on clinical oncology. World Journal of Stem Cells 2018; 10(12): 183-195 doi: 10.4252/wjsc.v10.i12.183
|
| 76 |
Bandana Chakravarti, Tahseen Akhtar, Byanju Rai, Manisha Yadav, Jawed Akhtar Siddiqui, Shailendra Kumar Dhar Dwivedi, Ravi Thakur, Anup Kumar Singh, Abhishek Kumar Singh, Harish Kumar, Kainat Khan, Subhashis Pal, Srikanta Kumar Rath, Jawahar Lal, Rituraj Konwar, Arun Kumar Trivedi, Dipak Datta, Durga Prasad Mishra, Madan Madhav Godbole, Sabyasachi Sanyal, Naibedya Chattopadhyay, Atul Kumar. Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents. Journal of Medicinal Chemistry 2014; 57(19): 8010 doi: 10.1021/jm500873e
|
| 77 |
Anine Crous, Heidi Abrahamse. Low-Intensity Laser Irradiation at 636 nm Induces Increased Viability and Proliferation in Isolated Lung Cancer Stem Cells. Photomedicine and Laser Surgery 2016; 34(11): 525 doi: 10.1089/pho.2015.3979
|
| 78 |
Eunkyung Chung, Inkyung Oh, Kil Yeon Lee. Characterization of sphere-forming HCT116 clones by whole RNA sequencing. Annals of Surgical Treatment and Research 2016; 90(4): 183 doi: 10.4174/astr.2016.90.4.183
|
| 79 |
Zhe Wang, Margot Zöller. Exosomes, metastases, and the miracle of cancer stem cell markers. Cancer and Metastasis Reviews 2019; 38(1-2): 259 doi: 10.1007/s10555-019-09793-6
|
| 80 |
Kenly Wuputra, Chia-Chen Ku, Kohsuke Kato, Deng-Chyang Wu, Shigeo Saito, Kazunari K. Yokoyama. Translational models of 3-D organoids and cancer stem cells in gastric cancer research. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02521-4
|
| 81 |
Sheng-Ying Xiao, Zhi-Guang Yan, Xiao-Dong Zhu, Jun Qiu, Yi-Chen Lu, Fu-Ren Zeng. LncRNA DLGAP1-AS2 promotes the radioresistance of rectal cancer stem cells by upregulating CD151 expression via E2F1. Translational Oncology 2022; 18: 101304 doi: 10.1016/j.tranon.2021.101304
|
| 82 |
Seung Yeop Oh, Se Hwa Sohn, Hyunee Yim, Dakeun Lee, Kwang Wook Suh, Young Bae Kim. ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer. Journal of Surgical Oncology 2015; 111(2): 243 doi: 10.1002/jso.23792
|
| 83 |
Rubén Varela-Calviño, Oscar J Cordero. Stem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis. World Journal of Immunology 2015; 5(2): 68-77 doi: 10.5411/wji.v5.i2.68
|
| 84 |
Amal F. Gharib, Sally M. Shalaby, Nermin Raafat, Walaa M.S. Fawzy, Nabila H. Abdel Hakim. Assessment of neutralizing interleukin-4 effect on CD133 gene expression in colon cancer cell line. Cytokine 2017; 97: 66 doi: 10.1016/j.cyto.2017.05.022
|
| 85 |
Álisson Coldebella da Silva, Juliete Nathali Scholl, Amanda de Fraga Dias, Augusto Ferreira Weber, Fernanda Bueno Morrone, Olga Cruz-López, Ana Conejo-García, Joaquín María Campos, Jean Sévigny, Fabrício Figueiró, Ana Maria Oliveira Battastini. Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme. Purinergic Signalling 2023; doi: 10.1007/s11302-023-09975-6
|
| 86 |
Amirhossein Davoodvandi, Mohammad Shabani Varkani, Cain C. T. Clark, Sadegh Jafarnejad. Quercetin as an anticancer agent: Focus on esophageal cancer. Journal of Food Biochemistry 2020; 44(9) doi: 10.1111/jfbc.13374
|
| 87 |
Yanmei Zhang, Zixuan Wang, Qifan Hu, Hao Luo, Bingchuan Lu, Yunhe Gao, Zhi Qiao, Yongsen Zhou, Yongcong Fang, Jin Gu, Ting Zhang, Zhuo Xiong. 3D Bioprinted GelMA‐Nanoclay Hydrogels Induce Colorectal Cancer Stem Cells Through Activating Wnt/β‐Catenin Signaling. Small 2022; 18(18) doi: 10.1002/smll.202200364
|
| 88 |
Kyung-Ho Jung, Jin Hee Lee, Mina Kim, Eun Ji Lee, Young Seok Cho, Kyung-Han Lee, Alexei Bogdanov. Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by 89Zr Immuno-PET. Molecular Imaging 2022; 2022 doi: 10.1155/2022/4906934
|
| 89 |
Jiaqi Wang, Yuhki Yokoyama, Haruka Hirose, Yuki Shimomura, Saki Bonkobara, Hiroaki Itakura, Shihori Kouda, Yoshihiro Morimoto, Kazumasa Minami, Hidekazu Takahashi, Satoshi Shibata, Shogo Kobayashi, Mamoru Uemura, Susumu Tanaka, Xin Wu, Shinji Tanaka, Masaki Mori, Hirofumi Yamamoto. Functional assessment of miR‑1291 in colon cancer cells. International Journal of Oncology 2022; 60(2) doi: 10.3892/ijo.2022.5303
|
| 90 |
Alisa Gisina, Yan Kim, Konstantin Yarygin, Alexey Lupatov. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons. International Journal of Molecular Sciences 2023; 24(24): 17398 doi: 10.3390/ijms242417398
|
| 91 |
Sang Yun Kim, Sungyeon Park, Suhyun Kim, Jesang Ko. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer. Carcinogenesis 2024; 45(5): 300 doi: 10.1093/carcin/bgad093
|
| 92 |
|
| 93 |
Wei Zhang, Huanran Chen, Shengqing Lv, Hui Yang. High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma. Molecular Neurobiology 2016; 53(4): 2354 doi: 10.1007/s12035-015-9187-1
|
| 94 |
Mahdi Abbasian, Elham Mousavi, Zahra Arab‐Bafrani, Amirhossein Sahebkar. The most reliable surface marker for the identification of colorectal cancer stem‐like cells: A systematic review and meta‐analysis. Journal of Cellular Physiology 2019; 234(6): 8192 doi: 10.1002/jcp.27619
|
| 95 |
Daniel Winardi, Hung-Pei Tsai, Chee-Yin Chai, Chia-Li Chung, Joon-Khim Loh, Yung-Hsiang Chen, Ching-Liang Hsieh. Correlation of Altered Expression of the Autophagy Marker LC3B with Poor Prognosis in Astrocytoma. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/723176
|
| 96 |
Mariele Montanari, Michele Guescini, Ozan Gundogdu, Francesca Luchetti, Paola Lanuti, Caterina Ciacci, Sabrina Burattini, Raffaella Campana, Claudio Ortolani, Stefano Papa, Barbara Canonico. Extracellular Vesicles from Campylobacter jejuni CDT-Treated Caco-2 Cells Inhibit Proliferation of Tumour Intestinal Caco-2 Cells and Myeloid U937 Cells: Detailing the Global Cell Response for Potential Application in Anti-Tumour Strategies. International Journal of Molecular Sciences 2022; 24(1): 487 doi: 10.3390/ijms24010487
|
| 97 |
Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán, Jose Prados. Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-511
|
| 98 |
Davide Brocco, Pasquale Simeone, Davide Buca, Pietro Di Marino, Michele De Tursi, Antonino Grassadonia, Laura De Lellis, Maria Teresa Martino, Serena Veschi, Manuela Iezzi, Simone De Fabritiis, Marco Marchisio, Sebastiano Miscia, Alessandro Cama, Paola Lanuti, Nicola Tinari. Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer. Cancers 2022; 14(5): 1357 doi: 10.3390/cancers14051357
|
| 99 |
Tzu-Cheng Sung, Wei-Lun Huang, Lee-Kiat Ban, Henry Hsin-Chung Lee, Jia-Hua Wang, Her-Young Su, Shih Hsi Jen, Yen-Hsiang Chang, Jen-Ming Yang, Akon Higuchi, Qingsong Ye. Enrichment of cancer-initiating cells from colon cancer cells through porous polymeric membranes by a membrane filtration method. Journal of Materials Chemistry B 2020; 8(46): 10577 doi: 10.1039/D0TB02312D
|
| 100 |
Nisitha Wijewantha, Sanam Sane, Morgan Eikanger, Ryan M. Antony, Rashaun A. Potts, Lydia Lang, Khosrow Rezvani, Grigoriy Sereda. Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles. Cancers 2023; 15(4): 1145 doi: 10.3390/cancers15041145
|
| 101 |
Pavel Pitule, Miroslava Cedikova, Ondrej Daum, Jan Vojtisek, Ondrej Vycital, Petr Hosek, Vladislav Treska, Ondrej Hes, Milena Kralickova, Vaclav Liska. Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/432139
|
| 102 |
M Orciani, S Davis, G Appolloni, R Lazzarini, M Mattioli-Belmonte, R A Ricciuti, M Boscaro, R Di Primio, G Arnaldi. Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. Cancer Gene Therapy 2015; 22(1): 9 doi: 10.1038/cgt.2014.63
|
| 103 |
Salimeh Chenaghlou, Alireza Khataee, Roghayeh Jalili, Mohammad-Reza Rashidi, Balal Khalilzadeh, Sang Woo Joo. Gold nanostar-enhanced electrochemiluminescence immunosensor for highly sensitive detection of cancer stem cells using CD133 membrane biomarker. Bioelectrochemistry 2021; 137: 107633 doi: 10.1016/j.bioelechem.2020.107633
|
| 104 |
Kevin Dzobo, Musalula Sinkala. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis. OMICS: A Journal of Integrative Biology 2021; 25(5): 313 doi: 10.1089/omi.2021.0025
|
| 105 |
Diana Cervantes-Madrid, Yvonne Wettergren, Peter Falk, Kent Lundholm, Annika G. Asting. DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3206-8
|
| 106 |
Muhammad Yasir Anwar, Grant R. Williams, Ravi K. Paluri. CAR T Cell Therapy in Pancreaticobiliary Cancers: a Focused Review of Clinical Data. Journal of Gastrointestinal Cancer 2021; 52(1): 1 doi: 10.1007/s12029-020-00457-1
|
| 107 |
Sergey Koshkin, Anna Danilova, Grigory Raskin, Nikolai Petrov, Olga Bajenova, Stephen J. O’Brien, Alexey Tomilin, Elena Tolkunova. Primary cultures of human colon cancer as a model to study cancer stem cells. Tumor Biology 2016; 37(9): 12833 doi: 10.1007/s13277-016-5214-8
|
| 108 |
Woojung Shin, Zhe Su, S. Stephen Yi, Hyun Jung Kim. Single-cell transcriptomic mapping of intestinal epithelium that undergoes 3D morphogenesis and mechanodynamic stimulation in a gut-on-a-chip. iScience 2022; 25(12): 105521 doi: 10.1016/j.isci.2022.105521
|
| 109 |
G. V. Gerashchenko, I. M. Vagina, Yu. V. Vagin, Z. Yu. Tkachuk, V. I. Kashuba. Expression pattern of immune- and cancer-associated genes in peripheral blood of mice bearing melanoma cells. Biopolymers and Cell 2019; 35(4): 313 doi: 10.7124/bc.000A0D
|
| 110 |
Christina Valbirk Konrad, Reshma Murali, Binitha Anu Varghese, Radhika Nair. The role of cancer stem cells in tumor heterogeneity and resistance to therapy. Canadian Journal of Physiology and Pharmacology 2017; 95(1): 1 doi: 10.1139/cjpp-2016-0079
|
| 111 |
Eriko Tanabe, Misaho Kitayoshi, Kiyomu Fujii, Hitoshi Ohmori, Yi Luo, Yui Kadochi, Shiori Mori, Rina Fujiwara, Yukiko Nishiguchi, Takamitsu Sasaki, Hiroki Kuniyasu. Fatty acids inhibit anticancer effects of 5-fluorouracil in mouse cancer cell lines. Oncology Letters 2017; 14(1): 681 doi: 10.3892/ol.2017.6190
|
| 112 |
Dong-Wook Min, Hwang-Phill Kim, Jinhyun Kim, Xianyu Wen, Sungsik Kim, Young-Won Cho, Yoojoo Lim, Sang-Hyun Song, Sae-Won Han, Sunghoon Kwon, Gyeong Hoon Kang, Tae-You Kim. Phenotype-based single cell sequencing identifies diverse genetic subclones in CD133 positive cancer stem cells. Biochemical and Biophysical Research Communications 2021; 558: 209 doi: 10.1016/j.bbrc.2020.09.005
|
| 113 |
Manali Haniti Mohd-Zahid, Siti Nadiah Zulkifli, Che Azurahanim Che Abdullah, JitKang Lim, Sharida Fakurazi, Kah Keng Wong, Andee Dzulkarnaen Zakaria, Norzila Ismail, Vuk Uskoković, Rohimah Mohamud, Iskandar Z. A. Gold nanoparticles conjugated with anti-CD133 monoclonal antibody and 5-fluorouracil chemotherapeutic agent as nanocarriers for cancer cell targeting. RSC Advances 2021; 11(26): 16131 doi: 10.1039/D1RA01093J
|
| 114 |
Kevin R Ginnebaugh, Aamir Ahmad, Fazlul H Sarkar. The therapeutic potential of targeting the epithelial–mesenchymal transition in cancer. Expert Opinion on Therapeutic Targets 2014; 18(7): 731 doi: 10.1517/14728222.2014.909807
|
| 115 |
Paige M. Glumac, Colleen L. Forster, Hong Zhou, Paari Murugan, Shilpa Gupta, Aaron M. LeBeau. The identification of a novel antibody for CD133 using human antibody phage display. The Prostate 2018; 78(13): 981 doi: 10.1002/pros.23656
|
| 116 |
Florencia Paula Madorsky Rowdo, Antonela Barón, Erika María Von Euw, José Mordoh. In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells. Oncology Reports 2017; 37(3): 1367 doi: 10.3892/or.2017.5363
|
| 117 |
Jia-Hua Wang, Lee-Kiat Ban, Henry Hsin-Chung Lee, Yen-Hung Chen, Hui-Yu Lin, Zhe-Wei Zhu, Her-Young Su, Akihiro Umezawa, Abdulrahman I. Almansour, Natarajan Arumugam, Raju Suresh Kumar, Gwo-Jang Wu, Akon Higuchi. Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters. Polymers 2021; 13(19): 3411 doi: 10.3390/polym13193411
|